Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avalo Therapeutics (AVTX) Change in Inventory (2017 - 2023)

Avalo Therapeutics filings provide 7 years of Change in Inventory readings, the most recent being -$18000.0 for Q3 2023.

  • On a quarterly basis, Change in Inventory fell 1700.0% to -$18000.0 in Q3 2023 year-over-year; TTM through Jun 2024 was -$18000.0, a 260.0% decrease, with the full-year FY2023 number at -$20000.0, down 11.11% from a year prior.
  • Change in Inventory hit -$18000.0 in Q3 2023 for Avalo Therapeutics, down from -$1000.0 in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $68294.0 in Q4 2019 to a low of -$411736.0 in Q2 2019.
  • Median Change in Inventory over the past 5 years was -$3000.0 (2020), compared with a mean of -$29155.1.
  • Biggest five-year swings in Change in Inventory: skyrocketed 600.0% in 2021 and later tumbled 1700.0% in 2023.
  • Avalo Therapeutics' Change in Inventory stood at $68294.0 in 2019, then tumbled by 108.79% to -$6000.0 in 2020, then skyrocketed by 466.67% to $22000.0 in 2021, then crashed by 109.09% to -$2000.0 in 2022, then plummeted by 800.0% to -$18000.0 in 2023.
  • The last three reported values for Change in Inventory were -$18000.0 (Q3 2023), -$1000.0 (Q2 2023), and -$1000.0 (Q1 2023) per Business Quant data.